After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...
Novavax Inc. closed 63.58% short of its 52-week high of $23.86, which the company reached on June 6th.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback